ClinicalTrials.Veeva

Menu

Ultrasound-guided Axillary Vein Access Versus Cephalic Venous Cutdown for Implantation of Cardiac Electronic Devices.

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Implantable Cardioverter-defibrillator
Pacemaker

Treatments

Device: Cephalic vein access
Device: Ultrasound-guided axillary vein access

Study type

Interventional

Funder types

Other

Identifiers

NCT04649788
69HCL19_0540
ANSM (Other Identifier)

Details and patient eligibility

About

Venous access is a fundamental step in lead insertion for endovenous cardiac implantable electronic devices (CIED). Cephalic vein cutdown is the most widely used technique in Europe. Ultrasound-guided axillary vein access is a promising alternative but there is a lack of clinical evidence supporting this technique.

The purpose of this study is to compare the efficacy and safety of ultrasound-guided axillary vein access versus cephalic venous cutdown for implantation of endovenous CIED.

Half of patients is implanted using an ultrasound-guided axillary vein puncture. The other half is implanted using a cephalic vein cutdown. After venous access is achieved, implantation procedure is identical in the two arms.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Indication for endovenous pacemaker or cardioverter-defibrillator (single or double room)

Exclusion criteria

  • History of previously implanted endocardial lead
  • Indication for cardiac resynchronization therapy
  • Impossibility of venous access
  • Unable/unwilling to provide informed consent
  • Pregnant or breastfeeding woman
  • Participating in another clinical study which can interfere with this study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Ultrasound-guided axillary vein access
Active Comparator group
Description:
This group of patients will receive the cardiac implantable electronic device with ultrasound-guided axillary venous access.
Treatment:
Device: Ultrasound-guided axillary vein access
Cephalic vein access
Active Comparator group
Description:
This group of patients will receive the cardiac implantable electronic device with cephalic venous access.
Treatment:
Device: Cephalic vein access

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems